Science
Mechanism of Action
Acting as a key signaling molecule, SH-Oligopeptide-1 precisely targets Epidermal Growth Factor (EGF) receptors on the surface of skin cells. This specific binding initiates a complex intracellular cascade, promoting the proliferation and differentiation of epidermal cells, thereby accelerating cellular turnover. The peptide actively enhances the biosynthesis of crucial extracellular matrix components, including collagen and elastin, which are vital for maintaining skin firmness and elasticity. Furthermore, its potent anti-inflammatory properties contribute to soothing irritated skin, improving barrier function, and aiding in scar reduction.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
Data not available to assess dusting potential or typical market concentrations for this specific compound.
The Formula
Formulation
Stability
Oligopeptide-1 (EGF) is highly sensitive to pH; precise pH adjustment of the cream to within 5.0-8.0 is crucial before adding a diluted EGF solution. It is also susceptible to enzymatic decomposition by microorganisms, necessitating stringent control over microbial contamination during processing. The ingredient should be incorporated in the final formulation step, ensuring temperatures remain below 45℃. As a medium-sized, polar molecule, a specialized delivery system may be required for optimal dermal penetration.
Conflicts
- Microbial contamination (leads to decomposition and loss of activity)
- Extreme pH values outside the 5.0-8.0 range
- High temperatures (above 45℃ during addition)
Safety
Safety Profile
While the combined INCI name OLIGOPEPTIDE-107 SH-OLIGOPEPTIDE-1 lacks a direct CIR review, the SH-Oligopeptide-1 (EGF) component is generally considered safe for cosmetic use, being biodegradable and free from animal-derived materials. Current research suggests that topically applied growth factors do not penetrate deeply enough to influence systemic cell growth. A recent literature review found no evidence that topical recombinant human EGF stimulates cancer cell proliferation, noting that EGF is mitogenic (stimulates cell proliferation) but not mutagenic. However, individuals with psoriasis or elevated skin cancer risk factors should consult a healthcare professional. It is not found on EWG's Restricted or Unacceptable Lists and is not considered carcinogenic in humans.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This peptide offers significant clinical promise for targeted skin concerns like aging, hyperpigmentation, and acne, operating through precise cellular signaling, although comprehensive long-term safety data in cosmetic applications is still evolving and warrants consideration.
Related
Similar Ingredients
Finding similar ingredients…